Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
3.020
-0.150 (-4.73%)
Apr 25, 2025, 11:53 AM EDT - Market open
Clene Employees
As of December 31, 2024, Clene had 76 total employees, including 75 full-time and 1 part-time employees. The number of employees decreased by 9 or -10.59% compared to the previous year.
Employees
76
Change (1Y)
-9
Growth (1Y)
-10.59%
Revenue / Employee
$4,500
Profits / Employee
-$518,421
Market Cap
26.07M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 76 | -9 | -10.59% |
Dec 31, 2023 | 85 | -1 | -1.16% |
Dec 31, 2022 | 86 | -16 | -15.69% |
Dec 31, 2021 | 102 | 28 | 37.84% |
Dec 31, 2020 | 74 | - | - |
CLNN News
- 11 days ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 24 days ago - Clene to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 4 weeks ago - Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 6 weeks ago - Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment - GlobeNewsWire
- 7 weeks ago - Clene to Present at the 37TH Annual Roth Conference - GlobeNewsWire
- 2 months ago - Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11 - Accesswire
- 2 months ago - Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction - GlobeNewsWire
- 4 months ago - FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS - GlobeNewsWire